SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 21, 16:15
617.60
-6.1 (-0.98%)
VOLUME 110,613
LIVE
NSE
Nov 21, 16:15
617.45
-6 (-0.96%)
VOLUME 1,528,026

Stock Advice on Ranbaxy Laboratories

Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
Be careful while betting on midcaps; like Kotak: Dimensions 

10.00 am | 21 Nov 2014 |  Source: CNBC-TV18

Ajay Srivastava is bullish on cement, tyre, IT and pharma space. Among stocks, Srivastava likes JK Lakshmi, Shree cement, Sun Pharma, Lupin, Tech Mahi...

Here's why Sun, Lupin, DRL are still best pharma bets 

1.04 pm | 20 Nov 2014 |  Source: CNBC-TV18

Once the closure of the merger (Sun-Ranbaxy) is done and market begins to take due notice of the benefits that can come through on the acquisition the...

Here are few trading ideas from Mithil Pradhan 

12.48 pm | 20 Nov 2014 |  Source: CNBC-TV18

Watch the interview of Mithil Pradhan of Violet Arc Global Managers with Sonia Shenoy and Anuj Singhal on CNBC-TV18, in which he shared his readings a...

Here are top 10 stocks to keep an eye on November 20 

8.47 am | 20 Nov 2014 |  Source: CNBC-TV18

Here are top 10 stocks to keep an eye on November 20 - Axis Bank, Wockhardt, DLF, Ranbaxy, Alok Industries, Kotak Mahindra Bank, ING Vysya, Hindalco, ...

Super Six intraday picks for the day 

8.15 am | 13 Nov 2014 |  Source: CNBC-TV18

Meghana Malkan of malkansview.com suggests buying Ranbaxy Laboratories with a target of Rs 702-712 and UPL with a target of Rs 371-380....

Is Sun Pharma expensive at current valuations? 

4.20 pm | 11 Nov 2014 |  Source: CNBC-TV18

Purely from a short-term point of view there might not be too much of significant run up but purely on a fundamental basis Sun Pharma looks fairly str...

Sun Pharma a must in core portfolio: Experts 

3.38 pm | 11 Nov 2014 |  Source: CNBC-TV18

Market experts Nipun Mehta and Dilip Bhatdo see no negatives for Sun Pharma if the Ranbaxy deal goes through....

Buy IRB Infra, Ranbaxy, Adani Ports: Vishal B Malkan 

12.27 pm | 11 Nov 2014 |  Source: CNBC-TV18

Vishal B Malkan of malkansview.com is of the view that one can buy Adani Ports for a target price of Rs 315 and Indiabulls Real Estate for a target pr...

Bull's Eye: Buy Bharat Forge, Ashok Leyland, Ranbaxy Labs 

8.54 am | 11 Nov 2014 |  Source: CNBC-TV18

Vishal B Malkan, malkansview.com advises buying IRB Infrastructure for a target price of Rs 285 and Ranbaxy Labs for a target price of Rs 720....

Buy IRB Infra, OBC, Ranbaxy Laboratories: Vishal Malkan 

1.24 pm | 10 Nov 2014 |  Source: CNBC-TV18

Vishal B Malkan of malkansview.com recommends buying Ranbaxy Laboratories for a target price of Rs 735 and Oriental Bank of Commerce for a target pric...

Bull's Eye: Buy Bharat Forge, Titan, OBC, Ranbaxy Labs 

8.59 am | 10 Nov 2014 |  Source: CNBC-TV18

Manav Chopra, Nirmal Bang advises buying Bharat Forge for a target price of Rs 870 and Adani Power for a target price of Rs 54....

Super Six: Top buying ideas for November 10

8.26 am | 10 Nov 2014 |  Source: CNBC-TV18

Meghana Malkan of malkansview.com advises buying Ranbaxy Laboratories with a target of Rs 690-710 and IRB Infrastructure Developers with a target of R...

Buy Ranbaxy Laboratories at lower level: Deven Choksey 

11.30 am | 07 Nov 2014 |  Source: CNBC-TV18

Deven Choksey of KR Choksey Shares is of the view that one can buy Ranbaxy Laboratories at lower level....

'Bullish on CV space; like Ashok Leyland, Advanta Seeds' 

10.29 am | 07 Nov 2014 |  Source: CNBC-TV18

Deven Choksey of KR Choksey Shares believes many of the midcap stocks are doing rather well. He likes Advanta Seeds, which came out with good set of n...

Ranbaxy may suffer loss of $250 mn on approval woes: Expert 

9.41 am | 07 Nov 2014 |  Source: CNBC-TV18

Surajit Pal, pharma analyst, Prabhudas Lilladher, expects Teva, Mylan, Sandoz and Dr Reddy’s Laboratories to benefit from this loss....

Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.